Lipoic Acid and Vitamin D Composition for Neurodegenerative Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cerebral aging and neurodegenerative diseases, such as Alzheimer's and Parkinson's, are often ineffective and can cause adverse effects, highlighting the need for a more effective and safer therapeutic solution.
Innovation Solution
A composition comprising lipoic acid and vitamin D3 or vitamin D2, which acts synergistically to treat neurodegenerative diseases and peripheral neuropathies by reducing oxidative stress and preventing astrocyte damage, while being easy to prepare and economically advantageous.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for cerebral aging and neurodegenerative diseases are used, then some therapeutic effect may be achieved, but they are often ineffective and can cause adverse effects
Solution Approach 1:
The patent combines lipoic acid and vitamin D3 into a single composition to achieve synergistic therapeutic effects. Lipoic acid provides antioxidant protection while vitamin D3 supports neuronal health, together addressing multiple aspects of neurodegenerative disease pathology without the adverse effects of conventional treatments.
Solution Approach 2:
The invention changes the therapeutic parameters by using natural antioxidants (lipoic acid and vitamin D3) at specific dosage ranges (lipoic acid: 10-100 mg/day, vitamin D3: 1000-5000 IU/day) that provide therapeutic benefits while avoiding toxicity, unlike conventional pharmaceuticals that often require higher doses with more side effects.
2Reliability
If antioxidants are used to reduce oxidative stress in aging brains, then cognitive functions may be improved, but the brain has poor catalyst activity and low levels of protective antioxidant enzymes
Solution Approach 1:
The patent applies preliminary action by administering lipoic acid and vitamin D3 before significant neurodegenerative damage occurs. These supplements pre-load the brain with antioxidants that can neutralize free radicals before they cause cumulative damage to neurons and astrocytes, preventing cognitive decline rather than treating it after onset.
Solution Approach 2:
Lipoic acid acts as an intermediary antioxidant that regenerates other antioxidants in the brain. It donates electrons to neutralize free radicals and simultaneously regenerates vitamin C and vitamin E, amplifying the overall antioxidant defense system beyond what any single supplement could achieve alone.
3Stability of the object's composition
If iron accumulates in the brain during aging, then it is a natural process, but it causes oxidative stress and cell damage
Solution Approach 1:
The patent converts the harmful effect of iron accumulation into a benefit by using lipoic acid, which has iron-chelating properties. Lipoic acid binds to excess iron, preventing it from catalyzing harmful Fenton reactions that produce hydroxyl radicals. This transforms the iron accumulation problem into an opportunity for lipoic acid to exert its protective chelating effect.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of lipoic acid and vitamin D effectively treats neurodegenerative diseases and slows cerebral aging without significant adverse effects, as demonstrated by increased cell viability and reduced oxidative stress in astrocytes, enhancing the absorption rate across the blood-brain barrier.
Implementation Method 1
taking antioxidants combined with symptomatic drugs reduces oxidative stress and improves the cognitive functions in aging and the aging-related diseases
Implementation Method 2
lipoic acid is a strong chelator of divalent metal ions
Implementation Method 3
enhancing the absorption rate across the blood-brain barrier
Data Source
AI summary
The present invention regards a composition comprising lipoic acid, or an acceptable pharmaceutical or food grade salt thereof or a derivative thereof, and a vitamin D, preferably vitamin D3 and/or vitamin D2, for use in a method for the treatment of neurodegenerative diseases and/or for the treatment of peripheral neuropathies.